About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
AGIOS PHARMACEUTICALS, INC. (AGIO): Insider Trades and Fund Holdings
In the past 12 months, AGIOS PHARMACEUTICALS, INC. insiders reported no open-market purchases and 4 sales worth $1.14M; 4 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 26, 2026Planned saleSARAH GHEUENS (officer) filed notice to sell about $296,468 around Oct 26, 2026
- Oct 22, 2026Insider saleChief Medical Officer Sarah Gheuens sold $18,760 under a 10b5-1 plan
- Oct 22, 2026Planned saleSARAH GHEUENS (officer) filed notice to sell about $18,760 around Oct 22, 2026
- Oct 21, 2026Insider saleChief Medical Officer Sarah Gheuens sold $55,882 under a 10b5-1 plan
- Oct 21, 2026Planned saleSARAH GHEUENS (officer) filed notice to sell about $55,881 around Oct 21, 2026
- Aug 20, 2026CongressRep. Gilbert Ray Cisneros, Jr. buy $1K–$15K
- Aug 4, 2026Insider saleChief Medical Officer Sarah Gheuens sold $914,400 under a 10b5-1 plan
- Jul 1, 2026Insider saleChief Medical Officer Sarah Gheuens sold $150,503 under a 10b5-1 plan
- Mar 3, 2026CongressRep. Gilbert Ray Cisneros, Jr. buy $1K–$15K
- Dec 11, 2025CongressRep. Gilbert Ray Cisneros, Jr. buy $1K–$15K
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 23, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 23 | Sarah GheuensChief Medical Officer | ▼ SELL10b5-1 | $56K |
| Oct 23 | Sarah GheuensChief Medical Officer | ▼ SELL10b5-1 | $19K |
| Aug 6 | Sarah GheuensChief Medical Officer | ▼ SELL10b5-1 | $914K |
| Jul 2 | Sarah GheuensChief Medical Officer | ▼ SELL10b5-1 | $151K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Sarah Gheuens | Chief Medical Officer | 0 | $0 | 4 | $1.14M |
Trades by members of Congress
Reported under the STOCK Act. Amounts are ranges from the form. All Congress trades →
| Filed | Member | Type | Amount |
|---|---|---|---|
| Sep 10 | ▲ BUY | $1K–$15K | |
| Apr 7 | ▲ BUY | $1K–$15K | |
| Jan 12 | ▲ BUY | $1K–$15K |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →